Obbligazioni RHHBF
Di seguito è riportato l'elenco delle obbligazioni societarie Roche Holding Ltd. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| CCHGCY5317644Roche Holdings, Inc. 2.607% 13-DEC-2051 | 6,58% | 3,5 M | 61,30% | 2,61% | 2051-12-13 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766485Roche Holdings, Inc. 5.218% 08-MAR-2054 | 5,36% | 5 M | 98,33% | 5,22% | 2054-03-08 | 1,6 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY4184535Roche Holdings, Inc. 4.0% 28-NOV-2044 | 5,25% | 200 K | 87,78% | 4,00% | 2044-11-28 | 650 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| UUSU75000BT2ROCHE HLDGS 22/25 REGS | 5,23% | 0 | 99,27% | 2,13% | 2025-03-10 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY3666852Genentech, Inc. 5.25% 15-JUL-2035 | 5,20% | 2 M | 100,36% | 5,25% | 2035-07-15 | 288,45 M USD | 1.000,00 USD | 1.000,00 USD | Genentech, Inc. |
| CCHGCY5766483Roche Holdings, Inc. 4.985% 08-MAR-2034 | 5,19% | 4,26 M | 98,70% | 4,99% | 2034-03-08 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766486Roche Holdings, Inc. 5.218% 08-MAR-2054 | 5,13% | 5 M | 101,00% | 5,22% | 2054-03-08 | 1,6 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766481Roche Holdings, Inc. 4.909% 08-MAR-2031 | 5,09% | 8 M | 99,09% | 4,91% | 2031-03-08 | 750 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5317198Roche Holdings, Inc. 2.076% 13-DEC-2031 | 5,01% | 1,9 M | 84,78% | 2,08% | 2031-12-13 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766479Roche Holdings, Inc. 4.79% 08-MAR-2029 | 4,97% | 1,8 M | 99,31% | 4,79% | 2029-03-08 | 875,2 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885614Roche Holdings, Inc. 5.218% 08-MAR-2054 | 4,90% | 800 K | 103,80% | 5,22% | 2054-03-08 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5373738Roche Holdings, Inc. FRN 10-MAR-2025 | 4,88% | 2 M | 100,09% | 5,20% | 2025-03-10 | 750 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885612Roche Holdings, Inc. 4.592% 09-SEP-2034 | 4,81% | 1,52 M | 98,54% | 4,59% | 2034-09-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766484Roche Holdings, Inc. 4.985% 08-MAR-2034 | 4,81% | 66 K | 101,14% | 4,99% | 2034-03-08 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5317643Roche Holdings, Inc. 1.93% 13-DEC-2028 | 4,80% | 600 K | 90,24% | 1,93% | 2028-12-13 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698672Roche Holdings, Inc. FRN 13-NOV-2026 | 4,79% | 9,54 M | 100,98% | 5,34% | 2026-11-13 | 300 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| UUSU75000BL9ROCHE HLDGS 16/27 REGS | 4,77% | 0 | 95,39% | 2,38% | 2027-01-28 | 850 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| RRH0HROCHE HLDGS 16/26 REGS | 4,75% | 0 | 97,17% | 2,63% | 2026-05-15 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698943Roche Holdings, Inc. 5.489% 13-NOV-2030 | 4,70% | 900 K | 103,69% | 5,49% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698748Roche Holdings, Inc. 5.593% 13-NOV-2033 | 4,67% | 550 K | 105,82% | 5,59% | 2033-11-13 | 1,6 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| UUSU75000BP0ROCHE HLDGS 18/28 REGS | 4,66% | 0 | 96,67% | 3,63% | 2028-09-17 | 650 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766482Roche Holdings, Inc. 4.909% 08-MAR-2031 | 4,66% | 200 K | 101,20% | 4,91% | 2031-03-08 | 750 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY4391962Roche Holdings, Inc. 7.0% 01-MAR-2039 | 4,63% | 15 K | 120,31% | 7,00% | 2039-03-01 | 1,12 B USD | 1.000,00 USD | 2.000,00 USD | Roche Holdings, Inc. |
| UUSU75000BV7ROCHE HLDGS 22/27 REGS | 4,57% | 0 | 95,42% | 2,31% | 2027-03-10 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885610Roche Holdings, Inc. 4.203% 09-SEP-2029 | 4,46% | 300 K | 98,99% | 4,20% | 2029-09-09 | 900 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY4307677Roche Holdings, Inc. 3.0% 10-NOV-2025 | 4,43% | 456 K | 98,73% | 3,00% | 2025-11-10 | 506,05 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698942Roche Holdings, Inc. 5.338% 13-NOV-2028 | 4,42% | 200 K | 103,08% | 5,34% | 2028-11-13 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5141501Roche Holdings, Inc. 0.991% 05-MAR-2026 | 4,35% | 500 K | 96,02% | 0,99% | 2026-03-05 | 650 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698948Roche Holdings, Inc. 5.265% 13-NOV-2026 | 4,33% | 600 K | 101,66% | 5,27% | 2026-11-13 | 1,1 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766480Roche Holdings, Inc. 4.79% 08-MAR-2029 | 4,29% | 200 K | 101,81% | 4,79% | 2029-03-08 | 875,2 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| XXS281321161ROCHE F. EUR 24/44 MTN | 3,29% | 0 | 103,22% | 3,56% | 2044-05-03 | 850 M EUR | 1.000,00 EUR | 100.000,00 EUR | Roche Finance Europe BV |
| XXS272633509ROCHE F. EUR 23/36 MTN | 3,05% | 0 | 104,71% | 3,59% | 2036-12-04 | 900 M EUR | 1.000,00 EUR | 100.000,00 EUR | Roche Finance Europe BV |
| XXS259208840ROCHE F. EUR 23/35 MTN | 2,90% | 0 | 103,56% | 3,36% | 2035-02-27 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Roche Finance Europe BV |
| XXS119505607ROCHE FIN.EUROPE 15/25MTN | 2,54% | 0 | 99,67% | 0,88% | 2025-02-25 | 1 B EUR | 1.000,00 EUR | 1.000,00 EUR | Roche Finance Europe BV |
| XXS281321129ROCHE F. EUR 24/30 MTN | 2,54% | 0 | 103,28% | 3,23% | 2030-05-03 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Roche Finance Europe BV |
| XXS259208823ROCHE F. EUR 23/29 MTN | 2,50% | 0 | 102,95% | 3,20% | 2029-08-27 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Roche Finance Europe BV |
| XXS272633193ROCHE F. EUR 23/27 MTN | 2,46% | 0 | 102,35% | 3,31% | 2027-12-04 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Roche Finance Europe BV |
| CCH137173682ROCHE KAPIT. 24/39 | 0,95% | 0 | 102,80% | 1,17% | 2039-09-06 | 275 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3K2NXROCHE KAPITALMARKT AG 2022-25.02.37 GUARANTEED REG S | 0,90% | 0 | 101,10% | 1,00% | 2037-02-25 | 300 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3LRKJROCHE KAPITALMARKT AG 2023-15.09.38 | 0,88% | 0 | 113,17% | 1,95% | 2038-09-15 | 230 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| CCH137173681ROCHE KAPIT. 24/34 | 0,82% | 0 | 102,53% | 1,10% | 2034-09-06 | 420 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3LRKKROCHE KAPITALMARKT AG 2023-15.09.33 | 0,81% | 0 | 107,68% | 1,75% | 2033-09-15 | 190 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3K88AROCHE KAPITALMARKT AG 2022-23.09.32 GUARANTEED | 0,79% | 0 | 108,89% | 2,00% | 2032-09-23 | 375 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3K2RBROCHE KAPITALMARKT AG 2022-25.02.31 GUARANTEED REG S | 0,76% | 0 | 99,96% | 0,75% | 2031-02-25 | 625 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| CCH43376131ROCHE KAPITALMKT 18-30 | 0,68% | 0 | 100,37% | 0,75% | 2030-09-24 | 400 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| CCH137173680ROCHE KAPIT. 24/29 | 0,68% | 0 | 101,41% | 0,99% | 2029-09-06 | 250 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3K88BROCHE KAPITALMARKT AG 2022-23.06.26 GUARANTEED | 0,62% | 0 | 101,33% | 1,50% | 2026-06-23 | 425 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3LQ44ROCHE KAPITALMARKT AG 2023-15.09.28 | 0,62% | 0 | 103,61% | 1,60% | 2028-09-15 | 140 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| CCH35991540ROCHE KAPITALMKT 17-29 | 0,61% | 0 | 99,34% | 0,45% | 2029-03-23 | 350 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| AA3K2JZROCHE KAPITALMARKT AG 2022-25.02.27 GUARANTEED REG S | 0,61% | 0 | 99,77% | 0,50% | 2027-02-25 | 825 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| CCH43376130ROCHE KAPITALMKT 18-25 | 0,58% | 0 | 99,74% | 0,25% | 2025-09-24 | 500 M CHF | 5.000,00 CHF | 5.000,00 CHF | Roche Kapitalmarkt AG |
| CCHGCY5885609Roche Holdings, Inc. 4.203% 09-SEP-2029 | — | — | — | 4,20% | 2029-09-09 | 900 M USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885611Roche Holdings, Inc. 4.592% 09-SEP-2034 | — | — | — | 4,59% | 2034-09-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Roche Holdings, Inc. |